• Je něco špatně v tomto záznamu ?

Silencing of E-cadherin expression leads to increased chemosensitivity to irinotecan and oxaliplatin in colorectal cancer cell lines

V. Skarkova, A. Skarka, M. Manethova, AA. Stefanidi, E. Rudolf

. 2021 ; 40 (12) : 2063-2073. [pub] 20210602

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22011818

Colorectal carcinoma (CRC) is a leading malignant disease in most developed countries. In advanced stages it presents with metastatic dissemination and significant chemoresistance. Despite intensive studies, no convincing evidence has been published concerning the association of cadherins and epithelial-mesenchymal transition (EMT) as a direct cause of acquired chemoresistance in CRC. The present study was designed to investigate the role of E-cadherin in EMT and its associated chemosensitivity/chemoresistance in four immortalized CRC cell lines representing various stages of CRC development (i.e. HT29 and Caco-2-early, SW480 and SW620 late). The expression of E-cadherin gene CDH1 was downregulated by the specific siRNA. Cell proliferation and chemosensitivity to irinotecan (IT) and oxaliplatin (OPT) were detected using WST-1 and x-CELLigence Real Time analysis. Expression of selected EMT markers were tested and compared using RT-PCR and western blot analysis in both variants (E-cadherin silenced and non-silenced) of each cell line. We have discovered that downregulation of E-cadherin expression has a diverse effect on both cell proliferation as well as the expression of EMT markers in individual tested CRC cell lines, with Caco-2 cells being the most responsive. On the other hand, reduced E-cadherin expression resulted in increased sensitivity of all cell lines to IT and mostly to OPT which might be related to changes in intracellular metabolism of these drugs. These results suggest dichotomy of E-cadherin involvement in the phenotypic EMT spectrum of CRC and warrants further mechanistic studies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011818
003      
CZ-PrNML
005      
20220506130522.0
007      
ta
008      
220425s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1177/09603271211021479 $2 doi
035    __
$a (PubMed)34075792
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Skarkova, Veronika $u Department of Medical Biology and Genetics, Faculty of Medicine, 37740Charles University, Hradec Kralove, Czech Republic $1 https://orcid.org/000000024244799X
245    10
$a Silencing of E-cadherin expression leads to increased chemosensitivity to irinotecan and oxaliplatin in colorectal cancer cell lines / $c V. Skarkova, A. Skarka, M. Manethova, AA. Stefanidi, E. Rudolf
520    9_
$a Colorectal carcinoma (CRC) is a leading malignant disease in most developed countries. In advanced stages it presents with metastatic dissemination and significant chemoresistance. Despite intensive studies, no convincing evidence has been published concerning the association of cadherins and epithelial-mesenchymal transition (EMT) as a direct cause of acquired chemoresistance in CRC. The present study was designed to investigate the role of E-cadherin in EMT and its associated chemosensitivity/chemoresistance in four immortalized CRC cell lines representing various stages of CRC development (i.e. HT29 and Caco-2-early, SW480 and SW620 late). The expression of E-cadherin gene CDH1 was downregulated by the specific siRNA. Cell proliferation and chemosensitivity to irinotecan (IT) and oxaliplatin (OPT) were detected using WST-1 and x-CELLigence Real Time analysis. Expression of selected EMT markers were tested and compared using RT-PCR and western blot analysis in both variants (E-cadherin silenced and non-silenced) of each cell line. We have discovered that downregulation of E-cadherin expression has a diverse effect on both cell proliferation as well as the expression of EMT markers in individual tested CRC cell lines, with Caco-2 cells being the most responsive. On the other hand, reduced E-cadherin expression resulted in increased sensitivity of all cell lines to IT and mostly to OPT which might be related to changes in intracellular metabolism of these drugs. These results suggest dichotomy of E-cadherin involvement in the phenotypic EMT spectrum of CRC and warrants further mechanistic studies.
650    _2
$a CD antigeny $x genetika $x metabolismus $7 D015703
650    _2
$a protinádorové látky $x farmakologie $7 D000970
650    _2
$a kadheriny $x genetika $x metabolismus $7 D015820
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a kolorektální nádory $x farmakoterapie $x genetika $x metabolismus $7 D015179
650    12
$a chemorezistence $7 D019008
650    _2
$a epitelo-mezenchymální tranzice $7 D058750
650    _2
$a umlčování genů $7 D020868
650    _2
$a lidé $7 D006801
650    _2
$a irinotekan $x farmakologie $7 D000077146
650    _2
$a oxaliplatin $x farmakologie $7 D000077150
650    _2
$a malá interferující RNA $x genetika $7 D034741
655    _2
$a časopisecké články $7 D016428
700    1_
$a Skarka, Adam $u Department of Chemistry, Faculty of Sciences, 48282University of Hradec Kralove, Hradec Kralove, Czech Republic $1 https://orcid.org/0000000273556857
700    1_
$a Manethova, Monika $u The Fingerland Department of Pathology, Faculty of Medicine and University Hospital in Hradec Kralove, 37740Charles University, Hradec Kralove, Czech Republic $1 https://orcid.org/0000000300833283
700    1_
$a Stefanidi, Afroditi A $u Department of Medical Biology and Genetics, Faculty of Medicine, 37740Charles University, Hradec Kralove, Czech Republic
700    1_
$a Rudolf, Emil $u Department of Medical Biology and Genetics, Faculty of Medicine, 37740Charles University, Hradec Kralove, Czech Republic
773    0_
$w MED00009821 $t Human & experimental toxicology $x 1477-0903 $g Roč. 40, č. 12 (2021), s. 2063-2073
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34075792 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130515 $b ABA008
999    __
$a ok $b bmc $g 1789429 $s 1163017
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 40 $c 12 $d 2063-2073 $e 20210602 $i 1477-0903 $m Human & experimental toxicology $n Hum Exp Toxicol $x MED00009821
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...